Impact of a Direct Oral Anticoagulant Population Management Tool on Anticoagulation Therapy Monitoring in Clinical Practice

被引:15
作者
Valencia, Daniela [1 ]
Spoutz, Patrick [2 ]
Stoppi, Jaclyn [1 ]
Kibert, Jeffery L., II [3 ]
Allen, Arthur [4 ]
Parra, David [5 ,6 ]
Hough, Augustus [1 ]
机构
[1] West Palm Beach VA Med Ctr, 7305 North Mil Trail, W Palm Beach, FL 33410 USA
[2] Boise VA Med Ctr, Boise, ID USA
[3] William Jennings Bryan Dorn VA Med Ctr, Columbia, SC USA
[4] Salt Lake City VA Med Ctr, Salt Lake City, UT USA
[5] Vet Integrated Serv Network 8, Pharm Benefits Management, Bay Pines, FL USA
[6] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA
关键词
anticoagulants; drug monitoring; quality improvement; direct oral anticoagulants; ANTITHROMBOTIC THERAPY; ATRIAL-FIBRILLATION; CHEST GUIDELINE; DABIGATRAN; WARFARIN; OUTCOMES;
D O I
10.1177/1060028019835843
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The optimal monitoring and follow-up strategy for long-term direct oral anticoagulant (DOAC) therapy has not been established. Historically, at our medical center, DOAC patients were referred to a clinical pharmacy specialist managed anticoagulation clinic (AC) for monitoring via regularly scheduled encounters (face-to-face or telephone). Objective: To determine if implementation of a DOAC Population Management Tool (PMT) designed to identify patients who most likely require clinical review and possibly intervention, would improve the efficacy (interventions per patient) and efficiency (time invested to generate an intervention) of monitoring over AC practices. Methods: The DOAC PMT group included patients flagged as potentially having a dosing issue or history of valve replacement. The AC group included patients who were scheduled for routine DOAC follow-up. The quantity and character of interventions made were prospectively recorded and compared. Results: A total of 399 patients were included. Data were collected for 131 patients identified by the DOAC PMT, resulting in a review of 170 flags with a total of 94 interventions or 0.55 interventions per flag reviewed. For the AC group, 268 patients were evaluated, leading to 53 interventions or 0.20 interventions per patient encounter (P < 0.001 for comparison). The time to generate an intervention was 16 minutes in the DOAC PMT versus 64 minutes for the AC group. Conclusion and Relevance: A population-based approach to DOAC monitoring represents a more effective and efficient strategy to reduce missed opportunities for interventions between follow-up appointments while also increasing clinic access, particularly for patients who require immediate attention.
引用
收藏
页码:806 / 811
页数:6
相关论文
共 15 条
[1]   Evaluation of a pharmacist-led outpatient direct oral anticoagulant service [J].
Ashjian, Emily ;
Kurtz, Brian ;
Renner, Elizabeth ;
Yeshe, Robert ;
Barnes, Geoffrey D. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (07) :483-489
[2]   National Trends in Ambulatory Oral Anticoagulant Use [J].
Barnes, Geoffrey D. ;
Lucas, Eleanor ;
Alexander, G. Caleb ;
Goldberger, Zachary D. .
AMERICAN JOURNAL OF MEDICINE, 2015, 128 (12) :1300-+
[3]   Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration [J].
Borne, Ryan T. ;
O'Donnell, Colin ;
Turakhia, Mintu P. ;
Varosy, Paul D. ;
Jackevicius, Cynthia A. ;
Marzec, Lucas N. ;
Masoudi, Frederick A. ;
Hess, Paul L. ;
Maddox, Thomas M. ;
Ho, P. Michael .
BMC CARDIOVASCULAR DISORDERS, 2017, 17
[4]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[5]   Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran [J].
Ezekowitz, Michael D. ;
Connolly, Stuart ;
Parekh, Amit ;
Reilly, Paul A. ;
Varrone, Jeanne ;
Wang, Susan ;
Oldgren, Jonas ;
Themeles, Ellison ;
Wallentin, Lars ;
Yusuf, Salim .
AMERICAN HEART JOURNAL, 2009, 157 (05) :805-810
[6]   The Changing Landscape for Stroke Prevention in AF Findings From the GLORIA-AF Registry Phase 2 [J].
Huisman, Menno V. ;
Rothman, Kenneth J. ;
Paquette, Miney ;
Teutsch, Christine ;
Diener, Hans-Christoph ;
Dubner, Sergio J. ;
Halperin, Jonathan L. ;
Ma, Chang Sheng ;
Zint, Kristina ;
Elsaesser, Amelie ;
Bartels, Dorothee B. ;
Lip, Gregory Y. H. ;
Abban, Dzifa ;
Abdul, Nasser ;
Abelson, Mark ;
Ackermann, Alan ;
Adams, Fran ;
Adams, Luthando ;
Adragao, Pedro ;
Ageno, Walter ;
Aggarwal, Rajesh ;
Agosti, Sergio ;
Marin, Javier Aguila ;
Aguilar, Francisco ;
Linares, Julio Alberto Aguilar ;
Aguinaga, Luis ;
Ahmad, Zia ;
Ainsworth, Paul ;
Al Ghalayini, Kamal ;
Al Ismail, Saad ;
Alasfar, Abdelfatah ;
Alawwa, Abdul ;
Al-Dallow, Raed ;
Alderson, Lisa ;
Alexopoulos, Dimitrios ;
Ali, Abdullah ;
Ali, Malik ;
Aliyar, Pareed ;
Al-Joundi, Tammam ;
Al Mahameed, Soufian ;
Almassi, Hossein ;
Almuti, Khalid ;
Al-Obaidi, Mohamed ;
Alshehri, Mohamed ;
Altmann, Ute ;
Alves, Alvaro Rabelo, Jr. ;
Al-Zoebi, Ayham ;
Amara, Walid ;
Amelot, Mathieu ;
Amjadi, Nima .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (07) :777-785
[7]   Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report [J].
Kearon, Clive ;
Akl, Elie A. ;
Ornelas, Joseph ;
Blaivas, Allen ;
Jimenez, David ;
Bounameaux, Henri ;
Huisman, Menno ;
King, Christopher S. ;
Morris, Timothy A. ;
Sood, Namita ;
Stevens, Scott M. ;
Vintch, Janine R. E. ;
Wells, Philip ;
Woller, Scott C. ;
Moores, Lisa .
CHEST, 2016, 149 (02) :315-352
[8]   Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report [J].
Lip, Gregory Y. H. ;
Banerjee, Amitava ;
Boriani, Giuseppe ;
Chiang, Chern en ;
Fargo, Ramiz ;
Freedman, Ben ;
Lane, Deirdre A. ;
Ruff, Christian T. ;
Turakhia, Mintu ;
Werring, David ;
Patel, Sheena ;
Moores, Lisa .
CHEST, 2018, 154 (05) :1121-1201
[9]   Site-Level Variation in and Practices Associated With Dabigatran Adherence [J].
Shore, Supriya ;
Ho, P. Michael ;
Lambert-Kerzner, Anne ;
Glorioso, Thomas J. ;
Carey, Evan P. ;
Cunningham, Fran ;
Longo, Lisa ;
Jackevicius, Cynthia ;
Rose, Adam ;
Turakhia, Mintu P. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (14) :1443-1450
[10]   Adherence to dabigatran therapy and longitudinal patient outcomes: Insights from the Veterans Health Administration [J].
Shore, Supriya ;
Carey, Evan P. ;
Turakhia, Mintu P. ;
Jackevicius, Cynthia A. ;
Cunningham, Fran ;
Pilote, Louise ;
Bradley, Steven M. ;
Maddox, Thomas M. ;
Grunwald, Gary K. ;
Baron, Anna E. ;
Rumsfeld, John S. ;
Varosy, Paul D. ;
Schneider, Preston M. ;
Marzec, Lucas N. ;
Ho, P. Michael .
AMERICAN HEART JOURNAL, 2014, 167 (06) :810-817